GB Patent

GB2370839A — Immunogenic complex useful for disease control

Assigned to Individual · Expires 2002-07-10 · 24y expired

What this patent protects

The complex comprises at least one ribosomal complex, i.e a particulate complex essentially composed of the subunits of ribosomes, and at least one polynucleotide encoding a microbial or viral antigen. The immunogenic complex may be incorporated in a polymeric matrix or in microp…

USPTO Abstract

The complex comprises at least one ribosomal complex, i.e a particulate complex essentially composed of the subunits of ribosomes, and at least one polynucleotide encoding a microbial or viral antigen. The immunogenic complex may be incorporated in a polymeric matrix or in microparticles and is used to prepare compositions or vaccines for the treatment of diseases caused by microbes or viruses, e.g. whooping cough or candidiasis.

Drugs covered by this patent

Patent Metadata

Patent number
GB2370839A
Jurisdiction
GB
Classification
—
Expires
2002-07-10
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.